Join us at #ACMG2025
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR
@myome.com.bsky.social
We help families understand their DNA, and how it impacts their health throughout their lives, with secure and portable data using the latest technologies.
Join us at #ACMG2025
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR
Live webinar: Innovations in Clinical Testing for Oncology & Rare Diseases. Taking place on march 6th at 11am ET.
Our next roundtable covers the challenges & strategies for integrating vast, multi-modal datasets into their clinical testing workflows. hello.dnanexus.com/webinar/inno...
@dcgenomics.bsky.social @labcorp.bsky.social @premalshah.bsky.social h.bsky.social @myome.com
Today we are excited to launch CAD iPRS β a cutting-edge, genome-wide polygenic risk score for coronary artery disease. Empowering primary care to identify high-risk patients and personalize prevention strategies.
Read more here: prnewswire.com/news-release...
MyOmeβs Dr. Akash Kumar will speak at WashU Medicineβs Rare Disease Day event on:
π
Feb 20 | 1:45PM PT / 3:45PM CT
𧬠Shortening Diagnostic Timelines for Rare Diseases β A Whole-Genome Platform Approach
Join our discussion on clinical testing innovations that are enabling organizations to derive insights into #oncology & #raredisease. hello.dnanexus.com/webinar/inno...
@dcgenomics.bsky.social @labcorp.bsky.social @premalshah.bsky.social @myome.com
We're partnering with Novi Health to bring whole genome testing to employer health programs. Through this collaboration, employees and their families gain access to whole genome sequencing, integrated risk (with PRS) reports, and expert genetic counseling.
prn.to/4jzWF7T
MyOme's CEO, Premal S. Shah, PhD, is excited to speak at #PMWC2025 on Feb 6 at 2 PM. We'll discuss integrated polygenic risk scores for breast cancer & coronary artery disease. Learn more: pmwcintl.com/program/ #PrecisionMedicine
14.01.2025 17:49 β π 1 π 0 π¬ 0 π 0Big news! 𧬠Natera & MyOme launch iPRSβ’, a personalized tool to assess breast cancer risk. Backed by research, iPRS integrates >1M genetic markers & clinical inputs for accurate, cross-ancestry insights.
Learn more: ow.ly/mGsJ50UntLt
#BreastCancer #Genetics